Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Trilaciclib plus chemotherapy versus chemotherapy alone in patients with metastatic triple-negative breast cancer: a multicentre, randomised, open-label, phase 2 trial.

Tan AR, Wright GS, Thummala AR, Danso MA, Popovic L, Pluard TJ, Han HS, Vojnović Ž, Vasev N, Ma L, Richards DA, Wilks ST, Milenković D, Yang Z, Antal JM, Morris SR, O'Shaughnessy J.

Lancet Oncol. 2019 Nov;20(11):1587-1601. doi: 10.1016/S1470-2045(19)30616-3. Epub 2019 Sep 28.

PMID:
31575503
2.

An assessment of critical care capacity in the Gambia.

Touray S, Sanyang B, Zandrow G, Dibba F, Fadera K, Kanteh E, Danso M, Sanyang LN, Njie M, Johnson G, Sanyang A, Touray A.

J Crit Care. 2018 Oct;47:245-253. doi: 10.1016/j.jcrc.2018.07.022. Epub 2018 Jul 22.

PMID:
30059869
3.

Phase 1 study of seviteronel, a selective CYP17 lyase and androgen receptor inhibitor, in women with estrogen receptor-positive or triple-negative breast cancer.

Bardia A, Gucalp A, DaCosta N, Gabrail N, Danso M, Ali H, Blackwell KL, Carey LA, Eisner JR, Baskin-Bey ES, Traina TA.

Breast Cancer Res Treat. 2018 Aug;171(1):111-120. doi: 10.1007/s10549-018-4813-z. Epub 2018 May 9.

4.

Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update.

Hesketh PJ, Kris MG, Basch E, Bohlke K, Barbour SY, Clark-Snow RA, Danso MA, Dennis K, Dupuis LL, Dusetzina SB, Eng C, Feyer PC, Jordan K, Noonan K, Sparacio D, Somerfield MR, Lyman GH.

J Clin Oncol. 2017 Oct 1;35(28):3240-3261. doi: 10.1200/JCO.2017.74.4789. Epub 2017 Jul 31. Review.

PMID:
28759346
5.

The prevalence and pattern of chemotherapy-induced peripheral neuropathy among women with breast cancer receiving care in a large community oncology practice.

Simon NB, Danso MA, Alberico TA, Basch E, Bennett AV.

Qual Life Res. 2017 Oct;26(10):2763-2772. doi: 10.1007/s11136-017-1635-0. Epub 2017 Jun 29.

PMID:
28664460
6.

Altered expression of epidermal lipid bio-synthesis enzymes in atopic dermatitis skin is accompanied by changes in stratum corneum lipid composition.

Danso M, Boiten W, van Drongelen V, Gmelig Meijling K, Gooris G, El Ghalbzouri A, Absalah S, Vreeken R, Kezic S, van Smeden J, Lavrijsen S, Bouwstra J.

J Dermatol Sci. 2017 Oct;88(1):57-66. doi: 10.1016/j.jdermsci.2017.05.005. Epub 2017 May 18.

PMID:
28571749
7.

Ramucirumab With Eribulin Versus Eribulin in Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracycline and Taxane Therapy: A Multicenter, Randomized, Phase II Study.

Yardley DA, Reeves J, Dees EC, Osborne C, Paul D, Ademuyiwa F, Soliman H, Guthrie T, Andersen J, Krekow L, Choksi J, Daniel B, Danso M, Favret A, Oommen S, Brufsky A, Bromund JL, Lin Y, Ibrahim AB, Richards PD.

Clin Breast Cancer. 2016 Dec;16(6):471-479.e1. doi: 10.1016/j.clbc.2016.07.005. Epub 2016 Jul 29.

8.

Antiemetics: American Society of Clinical Oncology Focused Guideline Update.

Hesketh PJ, Bohlke K, Lyman GH, Basch E, Chesney M, Clark-Snow RA, Danso MA, Jordan K, Somerfield MR, Kris MG; American Society of Clinical Oncology.

J Clin Oncol. 2016 Feb 1;34(4):381-6. doi: 10.1200/JCO.2015.64.3635. Epub 2015 Nov 2.

PMID:
26527784
9.

Diverse regulation of claudin-1 and claudin-4 in atopic dermatitis.

Gruber R, Börnchen C, Rose K, Daubmann A, Volksdorf T, Wladykowski E, Vidal-Y-Sy S, Peters EM, Danso M, Bouwstra JA, Hennies HC, Moll I, Schmuth M, Brandner JM.

Am J Pathol. 2015 Oct;185(10):2777-89. doi: 10.1016/j.ajpath.2015.06.021. Epub 2015 Aug 28.

PMID:
26319240
10.

Explant cultures of atopic dermatitis biopsies maintain their epidermal characteristics in vitro.

van Drongelen V, Danso MO, Out JJ, Mulder A, Lavrijsen AP, Bouwstra JA, El Ghalbzouri A.

Cell Tissue Res. 2015 Sep;361(3):789-97. doi: 10.1007/s00441-015-2162-3. Epub 2015 Mar 18.

PMID:
25776938
11.

Exploring the potentials of nurture: 2(nd) and 3(rd) generation explant human skin equivalents.

Danso MO, van Drongelen V, Mulder A, Gooris G, van Smeden J, El Ghalbzouri A, Bouwstra JA.

J Dermatol Sci. 2015 Feb;77(2):102-9. doi: 10.1016/j.jdermsci.2014.12.002. Epub 2014 Dec 30.

PMID:
25600661
12.

An ex vivo human skin model for studying skin barrier repair.

Danso MO, Berkers T, Mieremet A, Hausil F, Bouwstra JA.

Exp Dermatol. 2015 Jan;24(1):48-54. doi: 10.1111/exd.12579. Epub 2014 Dec 8.

PMID:
25363465
13.

Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancer.

O'Shaughnessy J, Schwartzberg L, Danso MA, Miller KD, Rugo HS, Neubauer M, Robert N, Hellerstedt B, Saleh M, Richards P, Specht JM, Yardley DA, Carlson RW, Finn RS, Charpentier E, Garcia-Ribas I, Winer EP.

J Clin Oncol. 2014 Dec 1;32(34):3840-7. doi: 10.1200/JCO.2014.55.2984. Epub 2014 Oct 27.

PMID:
25349301
14.

Chemotherapy and targeted therapy for women with human epidermal growth factor receptor 2-negative (or unknown) advanced breast cancer: American Society of Clinical Oncology Clinical Practice Guideline.

Partridge AH, Rumble RB, Carey LA, Come SE, Davidson NE, Di Leo A, Gralow J, Hortobagyi GN, Moy B, Yee D, Brundage SB, Danso MA, Wilcox M, Smith IE.

J Clin Oncol. 2014 Oct 10;32(29):3307-29. doi: 10.1200/JCO.2014.56.7479. Epub 2014 Sep 2.

15.

Barrier properties of an N/TERT-based human skin equivalent.

van Drongelen V, Danso MO, Mulder A, Mieremet A, van Smeden J, Bouwstra JA, El Ghalbzouri A.

Tissue Eng Part A. 2014 Nov;20(21-22):3041-9. doi: 10.1089/ten.TEA.2014.0011. Epub 2014 Aug 4.

16.

TNF-α and Th2 cytokines induce atopic dermatitis-like features on epidermal differentiation proteins and stratum corneum lipids in human skin equivalents.

Danso MO, van Drongelen V, Mulder A, van Esch J, Scott H, van Smeden J, El Ghalbzouri A, Bouwstra JA.

J Invest Dermatol. 2014 Jul;134(7):1941-1950. doi: 10.1038/jid.2014.83. Epub 2014 Feb 11.

17.

Pathologic complete response after preoperative anti-HER2 therapy correlates with alterations in PTEN, FOXO, phosphorylated Stat5, and autophagy protein signaling.

Holmes FA, Espina V, Liotta LA, Nagarwala YM, Danso M, McIntyre KJ, Osborne CR, Anderson T, Krekow L, Blum JL, Pippen J, Florance A, Mahoney J, O'Shaughnessy JA.

BMC Res Notes. 2013 Dec 5;6:507. doi: 10.1186/1756-0500-6-507.

18.

Knock-down of filaggrin does not affect lipid organization and composition in stratum corneum of reconstructed human skin equivalents.

van Drongelen V, Alloul-Ramdhani M, Danso MO, Mieremet A, Mulder A, van Smeden J, Bouwstra JA, El Ghalbzouri A.

Exp Dermatol. 2013 Dec;22(12):807-12. doi: 10.1111/exd.12271.

PMID:
24164439
19.

Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic Breast Cancer.

Gucalp A, Tolaney S, Isakoff SJ, Ingle JN, Liu MC, Carey LA, Blackwell K, Rugo H, Nabell L, Forero A, Stearns V, Doane AS, Danso M, Moynahan ME, Momen LF, Gonzalez JM, Akhtar A, Giri DD, Patil S, Feigin KN, Hudis CA, Traina TA; Translational Breast Cancer Research Consortium (TBCRC 011).

Clin Cancer Res. 2013 Oct 1;19(19):5505-12. doi: 10.1158/1078-0432.CCR-12-3327. Epub 2013 Aug 21.

20.

Nature versus nurture: does human skin maintain its stratum corneum lipid properties in vitro?

Thakoersing VS, Danso MO, Mulder A, Gooris G, El Ghalbzouri A, Bouwstra JA.

Exp Dermatol. 2012 Nov;21(11):865-70. doi: 10.1111/exd.12031.

PMID:
23163653
21.

Phase II trial of weekly nanoparticle albumin-bound paclitaxel with carboplatin and trastuzumab as first-line therapy for women with HER2-overexpressing metastatic breast cancer.

Conlin AK, Seidman AD, Bach A, Lake D, Dickler M, D'Andrea G, Traina T, Danso M, Brufsky AM, Saleh M, Clawson A, Hudis CA.

Clin Breast Cancer. 2010 Aug 1;10(4):281-7. doi: 10.3816/CBC.2010.n.036.

22.

An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen.

Doane AS, Danso M, Lal P, Donaton M, Zhang L, Hudis C, Gerald WL.

Oncogene. 2006 Jun 29;25(28):3994-4008. Epub 2006 Feb 20.

PMID:
16491124

Supplemental Content

Support Center